Validation of the TMD Pain Screener in a Specialized Headache Center
Launched by DANISH HEADACHE CENTER · Dec 9, 2019
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women between the ages of 18 and 75 who are referred to the Danish Headache Center
- Exclusion Criteria:
- • No known pre-existing significant TMD or dental disease that can cause headaches
- • Anamnestic or clinical signs of a condition of any kind that is considered relevant by the investigating physician for participation in the study.
- • Patients who do not wish to be informed of the findings of presence of TMD
About Danish Headache Center
The Danish Headache Center is a leading research institution dedicated to advancing the understanding and treatment of headache disorders. As a prominent clinical trial sponsor, the center focuses on innovative therapeutic approaches and comprehensive patient care, aiming to improve the quality of life for individuals suffering from various types of headaches, including migraines and tension-type headaches. With a multidisciplinary team of experts in neurology, psychology, and pain management, the Danish Headache Center is committed to conducting rigorous clinical trials that contribute to evidence-based practices and the development of novel interventions in headache research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, , Denmark
Patients applied
Trial Officials
Henrik Winther Schytz, MD, PhD
Principal Investigator
Danish Headache Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials